Open access · OA
via OpenAlex
Inclusion Body Myositis: Update on Pathogenesis and Treatment
Elie Naddaf, Richard J. Barohn, Mazen M. Dimachkie
Neurotherapeutics · 2018 · ▲ 90 citations
Abstract
This 2018 review in Neurotherapeutics examines the latest updates on the pathogenesis and emerging treatment strategies for inclusion body myositis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s13311-018-0658-8
- Canonical
- link ↗
- Fetched
- 2026-09-25 MST
Cite this
APA
Naddaf, E., Barohn, R.J., & Dimachkie, M.M. (2018). Inclusion Body Myositis: Update on Pathogenesis and Treatment. <em>Neurotherapeutics</em>. https://doi.org/10.1007/s13311-018-0658-8
Vancouver
Naddaf E, Barohn RJ, Dimachkie MM. Inclusion Body Myositis: Update on Pathogenesis and Treatment. Neurotherapeutics. 2018. doi:10.1007/s13311-018-0658-8.
BibTeX
@article{elie2018Inclus,
title = {Inclusion Body Myositis: Update on Pathogenesis and Treatment},
author = {Elie Naddaf and Richard J. Barohn and Mazen M. Dimachkie},
journal = {Neurotherapeutics},
year = {2018},
doi = {10.1007/s13311-018-0658-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Journal of Frailty & Aging 2016
Citation only
FRAILTY ACROSS AGE GROUPS
Trends in Biochemical Sciences 2025
Citation only
Unlocking the protein code: how our organs age across a lifetime
Vascular 2023
Open access · CC-BY
Sex-specific frailty and chronological age normative carotid artery intima-media thickness values using the Canadian longitudinal study of aging
Journal of the Endocrine Society 2023
Open access · CC-BY
Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy
Cell 2019
Open access · OA
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
GeroScience 2025
Preprint · OA